Echocardiographic studies have demonstrated that the characteristic anatomic defect in idiopathic hypertrophic subaortic stenosis (IHSS) is asymmetric septal hypertrophy (ASH). Although echocardiographic diagnosis of ASH is extremely sensitive, occasionally adequate echocardiograms cannot be obtained. Moreover, echocardiographic assessment of the extent of the underlying cardiomyopathic process, known to be distributed nonuniformly, is limited to evaluation of the upper part of the ventricular septum and the posterobasal left ventricular (LV) free wall. To determine if a specific angiographic marker of ASH can be identified even in the absence of LV outflow obstruction, and to delineate the extent and degree of cardiomyopathic involvement of the ventricular septum and LV free wall in patients with ASH, septal and LV wall configuration and thickness were measured using simultaneous biventricular cineangiography. The ventricular septum was thicker in 16 patients with ASH (avg. 15.2 ± 1.5 mm) and in six patients with concentric left ventricular hypertrophy (LVH) due to aortic valve disease (avg. 12.8 ± 1.1 mm) than in seven normal subjects (avg. 6.7 ± 0.4 mm, P < 0.001). In normal subjects and in patients with concentric LV hypertrophy, the walls of the ventricular septum were parallel. In contrast, the walls diverged in ASH so that septal width increased significantly inferiorly. Thus, the ratio of upper to lower septal width was greater than 0.8 (avg. 1.04 ± 0.06 mm) in normals and LVH patients but less than 0.77 (avg. 0.70 + 0.01 mm, P < 0.001) in ASH patients. Furthermore, upper septal width and the ratio of upper to lower septal width in ASH were significantly greater in seven patients with LV outflow obstruction than in six patients without obstruction, suggesting that the upper septum bulges into the LV outflow tract to a greater extent in obstructive ASH. In addition, the LV free wall in ASH was nonuniformly thickened, whereas in LVH the hypertrophy was uniform. We conclude that angiographic delineation of the septum and LV free wall 1) demonstrates abnormalities that distinguish ASH from normal and concentrically hypertrophied hearts, 2) demonstrates abnormalities that distinguish obstructive from nonobstructive ASH, and 3) aids in characterizing the distribution of myopathic involvement in patients with ASH. 
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Idiopathic hypertrophic subaortic stenosis Interventricular septum Cardiac catheterization DEFINITIVE CLINICAL DIAGNOSIS of idiopathic hypertrophic subaortic stenosis (IHSS), until very recently, had relied largely on physical findings and hemodynamic abnormalities caused by or related to left ventricular outflow obstruction.' Echocardiographic studies in our laboratory have shown that when compared to the posterobasal left ventricular free wall, the ventricular septum is disproportionately hypertrophied in all patients with IHSS.2 3 Using asymmetric septal hypertrophy (ASH) as a sensitive marker of this disease, it was found that the majority of patients falling into the IHSS disease spectrum do not have obstruction. Hence, many patients will remain undiagnosed if the definitive diagnosis is based on findings that depend on the existence of outflow obstruction.
In addition, microscopic studies have demonstrated that although all patients with ASH have hypertrophied, bizarrely shaped, and maloriented cells in the ventricular septum, it appears that severely symptomatic patients without obstruction also have these cells distributed throughout the left ventricular free wall (unpublished observations). These cellular abnormalities presumably reflect the underlying myocardial defect present in ASH and probably are causally related to the extensive nonuniform thickening found in the left ventricular free wall of severely symptomatic patients without obstruction (unpublished observations). Hence, documentation of the extent and distribution of myocardial thickening may have important implications regarding cardiac function and patient prognosis. Circulation Measurements of the septal and free wall thickness were made from end-diastolic frames of the cineangiograms and corrected for error due to magnification. Premature ventricular contractions and immediately succeeding beats were excluded from study. The methods used are depicted in figure 1 . Cephalad, the septum was defined as terminating at the point at which the left and right ventricular outflow tracts crossed (fig. IA), and caudad, at the line drawn between the apices of the right and left ventricles. The area of the ventricular septum bounded by these limits and by the right and left ventricular endocardial surfaces was determined by planimetry; mean septal thickness was calculated by dividing the area by septal length (AB, fig. 1 ). To define the distribution of septal hypertrophy, septal thickness at the junction of the upper and middle thirds of the septum (C, fig. 1 ) was compared to the thickness at the junction of the mid and lower thirds (D, fig. 1 ) and expressed as a ratio (upper: lower septal thickness). End-systolic frames of the cineangiograms were measured similarly to study the systolic contraction pattern of the septum in patients with ASH and to determine how this compared with that in normal and in concentrically hypertrophied left ventricles. Accurate delineation of the endocardial borders of the in-A. Upper to lower septal ratio at end-diastole in the same groups of patients as in figure 3. of the inferior segment, the increased thickening could have been due to inclusion of part of the papillary muscle in measurement of wall thickness. Nonetheless, this apparent increase in thickness was 'not seen in either the normal or concentrically hypertrophied left ventricles. The left ventricular free wall viewed in both the right anterior oblique and the shallow left anterior oblique projections was uniformly thickened (RAO, 11.9 ± 0.8, LAO, 13.6 ± 1.2 mm). In this limited series it was not possible to distinguish between those patients with obstruction and those without from a study of the distribution of ventricular hypertrophy in the free wall.
Discussion
The results of this study confirm and extend previous findings4 and indicate that patients falling into the disease spectrum termed asymmetric septal hypertrophy (ASH) have a characteristic configurational abnormality of the interventricular septum, demonstrable by biventricular angiography that serves to distinguish hearts with ASH from both normal hearts and hearts hypertrophied secondary to aortic valvular disease. In normal individuals, the septum is seen at end-diastole as a thin-walled structure curving toward the right ventricle with the right and left ventricular endocardial surfaces remaining parallel until the septum merges inferiorly with the floor of the ventricles. During systole, septal shortening occurs and septal thickness increases ( fig. 2, upper panel) . However, the endocardial surfaces remain concave toward the left ventricle and parallel. In left ventricular hypertrophy due to aortic valve disease, the interventricular septum is thickened, but is otherwise similar to the nonhypertrophied ventricles ( fig. 2 , middle panel). Thus, the septum is concave toward the left or has a straight border; most importantly, the endocardial surfaces are parallel, both in diastole and systole.
In contrast, the interventricular septum in patients with ASH has a roughly triangular appearance ( fig. 2 difference from normal and concentrically hypertrophied hearts also can be discerned in quantitative terms insofar as there is no overlap between the patients with ASH and the other two groups if the ratios between the upper and lower septal widths are compared ( fig. 4) . Moreover, a comparison between the septal configuration in those patients with ASH with obstruction and those without obstruction demonstrated that the upper septal width and upper to lower septal ratios were significantly greater in obstructive ASH (fig. 5 ). This suggests that the upper septum bulges into the left ventricle to a greater extent in obstructive than in nonobstructive ASH. Whether this greater thickening is causally related to the presence of obstruction or is merely the result of it remains to be determined. Using echocardiography, a characteristic and highly sensitive marker of the IHSS spectrum of disease has been identified, i.e., the interventricular septum always is disproportionately thickened such that the ratio of septal to posterobasal left ventricular free wall thickness is equal to or greater than 1.3.2 Of the patients studied angiographically, the average ratio of mean septal width to posterior free wall width (as seen in the steep left anterior oblique postion) also was significantly greater in the patients with ASH than in the subjects with normal or concentrically hypertrophied left ventricles. Thus, the septal to posterior free wall ratio was 1.4 in the patients with ASH (with no patient having a value less than 1.0) but less than 0.9 in each of the subjects with either normal or concentrically hypertrophied hearts. This would appear to provide an angiographic marker of the IHSS spectrum of disease analogous to the echocardiographic marker.
It must be emphasized, however, that because of the presence of other radio-dense structures, it is not possible to define angiographically that portion of the posterobasal free wall through which the echocardiographic beam traverses (directly behind the posterior mitral leaflet and just below the atrioventricular ring). This consideration assumes importance since detailed necropsy studies have revealed that the septal to free wall ratio may be less than 1.3 in patients with nonobstructive ASH if more inferior portions of the posterior left ventricular free wall are measured (the free wall may become markedly thickened inferior to the posterior mitral leaflet). Thus, it is to be expected that some patients will be shown to have angiographically determined septal to posterior free wall ratios less than unity and therefore nondiagnostic of ASH. It would therefore appear that the septal to free wall ratio determined angiographically may not be as sensitive a marker of ASH as is the ratio determined echocardiographically. Angiographic delineation of the ventricular septal configuration, however, appears to define another highly characteristic diagnostic anatomic abnormality of patients with ASH. Definition of the precise specificity and sensitivity of this angiographic marker of the disease will require further study.
Although angiographic visualization of the posterobasal portion of the left ventricular free wall is not possible, measurement of other portions of the free wall may provide information relating to the extent and distribution of the primary myocardial defect in patients with nonobstructive ASH. Thus, in several of the severely symptomatic patients without obstruction studied, considerable hypertrophy of some portion of the left ventricular free wall was evident. Since obstruction was not present, high ventricular pressures cannot be evoked as a cause of the hypertrophy. The hypertrophy must therefore be assumed to be due to the primary myocardial defect present in this disease.3
In conclusion, this investigation indicates that the technique of biventricular angiography, by defining the configuration of the interveptricular septum, is of great value in establishing the diagnosis of ASH. It would also appear that an appreciation of the extent and distribution of the primary myocardial defect in the left ventricle can be obtained by angiography in patients with nonobstructive ASH. Whether or not this latter information will prove of value in defining such a patient's long-term prognosis remains to be determined.
